HeraMED (ASX:HMD) ROE % Adjusted to Book Value : -102.38% (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is HeraMED ROE % Adjusted to Book Value?

HeraMED's ROE % for the quarter that ended in Jun. 2024 was -785.23%. HeraMED's PB Ratio for the quarter that ended in Jun. 2024 was 7.67. HeraMED's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -102.38%.

HeraMED ROE % Adjusted to Book Value Historical Data

The historical data trend for HeraMED's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeraMED ROE % Adjusted to Book Value Chart

HeraMED Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-20.13

-23.03

-49.16

-23.20

HeraMED Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial							-92.85	-20.19	-19.13	-64.72	-102.38

Competitive Comparison of HeraMED's ROE % Adjusted to Book Value

For the Medical Devices subindustry, HeraMED's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HeraMED's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HeraMED's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where HeraMED's ROE % Adjusted to Book Value falls into.

HeraMED ROE % Adjusted to Book Value Calculation

HeraMED's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-272.40%	/	11.74
	=	-23.20%

HeraMED's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-785.23%	/	7.67
	=	-102.38%

HeraMED ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of HeraMED's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

HeraMED Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HeraMED Ltd (ASX:HMD) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

1I4:Germany

Address

201, 697 Burke Road, Suite 4, Camberwell, VIC, AUS, 3124

Website

https://www.hera-med.com

HeraMED Ltd is engaged in developing, connected pregnancy monitoring solutions for home and professional use. It has developed a foetal heartbeat monitor called HeraBEAT which is a medical-grade, clinically-validated, smart and connected Ultrasound Foetal Doppler device predominantly for use by an expectant mother to self-monitor her foetus' heart rate (FHR). It is also focused on the commercialization and deployment of its HeraCARE pregnancy monitoring solution. Geographically, the company generates a majority of its revenue from the United States of America followed by Australia and Israel.

HeraMED Headlines

No Headlines